510 Gender Differences in Outcomes Amongst Patients Undergoing Coronary Angiography M.Arstall 1,2,∗, R.Dreyer 1,3, R.Tavella 1,3, M.Worthley1,4, S. Worthley1,4, D. Chew5,6, C. Zeitz 1,3, J. Beltrame1,3 1 The University of Adelaide, Australia 2 Lyell McEwin Hospital, Australia 3 The Queen Elizabeth Hospital, Australia 4 Royal Adelaide Hospital, Australia 5 Flinders University, Australia 6 Flinders Medical Centre, Australia Background: Despite extensive research within gender differences in acute coronary syndrome’s (ACS) (i.e. myocardial infarction), there is comparatively little data on gender-based differences in registries pertaining to diagnostic catheterisation. Methods: The Coronary Angiogram Database of South Australia (CADOSA) Registry is a comprehensive database of all public cardiac catheterisation procedures performed within South Australia. Registry data for 2012 was utilised to assess gender differences in (a) procedure information for diagnostic coronary angiography, (b) in-hospital outcomes and (c) discharge referral status/medications. Results: Men N= 2825 Women N= 1388 p Age (mean±SD) 64± 12 66± 13 <0.001 Elective Angiography (n %) 1519 (57%) 790 (59%) 0.058 Angiography for ST-elevation myocardial infarction (STEMI) (n, %) 398 (155) 134 (10%) <0.001 Percutaneous coronary intervention (PCI) performed (n, %) 859 (32%) 275 (21%) <0.001 No Coronary Disease Finding (n, %) 318 (12%) 344 (26%) <0.001 In-hospital death (n, %) 30 (1%) 22 (2%) 0.195 Referral for coronary artery bypass grafting (n, %) 340 (13%) 104 (8%) <0.001 Cardiac rehabilitation referral (n, %) 925 (33%) 323 (23%) 0.001 Discharge Aspirin (n, %) 2340 (83%) 1024 (74%) <0.001 Discharge Statin (n, %) 2058 (73%) 914 (66%) <0.001 Discharge ACE Inhibitor (n, %) 1346 (48%) 525 (38%) <0.001 Discharge Beta blocker (n, %) 1420 (50%) 574 (41%) <0.001 Discharge Calcium channel blocker (n, %) 996 (35%) 428 (31%) 0.003 Conclusion:Consistent with ACS data, women are both less likely to undergo angiography for STEMI and receive less life saving PCI. On discharge, women are also managedpoorlyanddonot receiveappropriate cardiac referral or maintenance medications in comparison to men. http://dx.doi.org/10.1016/j.hlc.2013.05.512 511 Glomerular Filtration Rate Derived from Cystatin C is MorePredictiveofDeathFollowingCardiacSurgeryThan Creatinine Based Estimates J. Mooney1,2,∗, C. Chow1,2, B. Cuthbertson3,4, B. Croal 5, G. Hillis 1,6 1 The George Institute for Global Health, Sydney, Australia 2 Department of Cardiology, Westmead Hospital, Sydney, Australia 3 Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Canada 4 Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada 5 Department of Clinical Biochemistry, Aberdeen Royal Infirmary, Aberdeen, United Kingdom 6 Department of Cardiology, Concord Repatriation General Hospital, Sydney, Australia Background: Renal dysfunction predicts mortality after cardiac surgery. Estimated glomerular filtration rate (eGFR) and cystatin C are better predictors of postoperative death than creatinine alone. The relative prognostic value of newer methods of calculating eGFR with the CKD-EPI equation, including cystatin C, has not been analysed in this setting. Methods: A prospective cohort study was conducted of 1010 patients undergoing cardiac surgery. Creatinine and cystatin C was collected prior to surgery, and eGFR calculated from these. Clinical variables were collected, and post-operative vital status established. Results:Mean age was 66 years with 77%male. Average followupwas4.8 yearswith 141deaths.Renal functionwas a powerful and independent predictor of death however measured.After adjustmentwith theEUROSCORE, eGFR derived from cystatin C showed the strongest association with death, though other measures remained significant (see table). Receiver operating characteristic curves showed eGFRderived fromcystatinC showed the greatest predictive utility (see table). Conclusions: EstimatedGFR using cystatin C levels and the CKD-EPI equation are more powerful predictors of death following cardiac surgery than creatinine based measures. Marker Hazard Ratio 95% Confidence Interval P-valueArea under the Curve 95% Confidence Interval Cystatin C 2.05 1.57–2.69 0.000 0.67 0.62–0.72 eGFR (Modified Diet in Renal Disease) 0.98 0.97–0.99 0.001 0.61 0.58–0.66 eGFR (CKD-EPI) 0.98 0.96–0.99 0.000 0.63 0.58–0.68 eGFR (cystatin c CKD-EPI) 0.97 0.96–0.98 0.000 0.68 0.63–0.73 eGFR (creatinine and cystatin c CKD-EPI) 0.98 0.97–0.99 0.000 0.66 0.61–0.71 CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration. http://dx.doi.org/10.1016/j.hlc.2013.05.513
Read full abstract